Prescription Drug Provisions within the Inflation Discount Act of 2022
The Inflation Discount Act of 2022 (the Act)1 contains prescription drug provisions which have important implications for the pharmaceutical business and Medicare beneficiaries, similar to permitting the U.S. Division of Well being and Human Companies (HHS) to barter costs for sure high-cost Medicare lined medication (together with small molecule medication and biologics) and to implement the negotiated costs beginning… Read More »
